TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ZLAB

Zai Lab Ltd

Healthcare · Biotechnology

25.60$ +5.3% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Zai Lab Ltd (ZLAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 106 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZLAB
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.7 1.7 4.9 4.6 8.2 11 15 15 20 37 43 44 47 48 58 63 63 69 69 66 87 101 102 109 106 110 116 128 100 106 450
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 1.3 1.6 2.1 2.9 4.9 230 211 153 67 194 69 17 20 21 21 24 25 25 34 35 37 42 39 43 47 62 38 48 196
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 1.3 3.6 3.1 6.1 8.1 9.7 -214 -191 -116 -24 -150 -23 31 37 42 41 45 44 41 54 65 65 67 68 67 69 65 61 58 254
12 12 10 10 9.2 9.2 17 17 30 56 29 29 51 32 34 68 58 63 204 142 55 172 54 66 100 67 48 77 59 82 55 62 66 52 61 51 48 62 66 62 237
2.0 4.4 2.0 2.0 2.0 2.0 3.2 3.2 6.4 11 11 29 18 29 19 24 28 41 36 54 59 70 57 63 67 72 63 68 69 83 69 80 67 83 63 43 41 73 65 73 252
13 13 12 12 13 13 21 21 34 67 45 45 69 55 52 92 86 -119 36 54 59 70 57 129 166 139 111 135 127 165 124 141 133 135 124 122 118 135 131 135 518
-14 -14 -12 -12 -13 -13 -20 -20 -34 -67 -43 -43 -65 -52 -46 -84 -76 -95 -227 -171 -83 -219 -80 -99 -129 -97 -70 -90 -84 -124 -70 -76 -68 -68 -56 -55 -49 -69 -69 -76 -264
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 0.1 3.2 0.1 5.9 0.1 0.1 0.0 0.0 6.0 7.7 13 7.9 0.2 1.2 3.9 9.3 20 0.0 0.0 20 0.1 0.5 0.7 0.9 1.2 1.3 1.4 1.4 1.6 1.6 6.0
-13 -13 -12 -12 -13 -13 -21 -21 -34 -63 -42 -42 -65 -50 -51 -78 -51 -77 -233 -163 -96 -212 -82 -138 -161 -62 -49 -121 -69 -95 -53 -80 -42 -82 -48 -41 -36 -53 -50 -52 -191
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 – -5.8 -4.8 -3.9 -2.9 2.8 12 18 -6.4 7.8 -15 7.4 2.6 39 33 -36 -32 18 -9.2 -22 9.5 – – – – – – -2.9 1.4 -1.0 –
-13 -13 -12 -12 -13 -13 -21 -21 -34 -63 -42 -42 -65 -46 -48 -81 -64 -77 -233 -163 -96 -212 -82 -138 -161 -62 -49 -121 -69 -95 -53 -80 -42 -82 -48 -41 -36 -50 -51 -51 -188
-14 -14 -12 -12 -13 -13 -20 -20 -34 -63 -42 -42 -68 -42 -47 -79 -62 -94 -226 -162 -95 -210 -80 -136 -159 -134 -46 -119 -67 -119 -50 -77 -38 -75 -44 -36 -31 -48 -44 -46 -169

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?